- Home
- PULM vs WVVI Comparison
PULM vs WVVI Comparison
Compare PULM & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- WVVI
- Stock Information
- Founded
- PULM 2003
- WVVI 1983
- Country
- PULM United States
- WVVI United States
- Employees
- PULM N/A
- WVVI N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- WVVI Beverages (Production/Distribution)
- Sector
- PULM Health Care
- WVVI Consumer Staples
- Exchange
- PULM Nasdaq
- WVVI Nasdaq
- Market Cap
- PULM 33.2M
- WVVI 28.2M
- IPO Year
- PULM N/A
- WVVI N/A
- Fundamental
- Price
- PULM $5.62
- WVVI $4.81
- Analyst Decision
- PULM
- WVVI
- Analyst Count
- PULM 0
- WVVI 0
- Target Price
- PULM N/A
- WVVI N/A
- AVG Volume (30 Days)
- PULM 11.2K
- WVVI 10.4K
- Earning Date
- PULM 08-12-2025
- WVVI 08-12-2025
- Dividend Yield
- PULM N/A
- WVVI N/A
- EPS Growth
- PULM N/A
- WVVI N/A
- EPS
- PULM N/A
- WVVI N/A
- Revenue
- PULM $1,921,000.00
- WVVI $38,520,945.00
- Revenue This Year
- PULM N/A
- WVVI N/A
- Revenue Next Year
- PULM $134.88
- WVVI N/A
- P/E Ratio
- PULM N/A
- WVVI N/A
- Revenue Growth
- PULM N/A
- WVVI N/A
- 52 Week Low
- PULM $1.78
- WVVI $3.17
- 52 Week High
- PULM $10.40
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- PULM 32.49
- WVVI 35.35
- Support Level
- PULM $5.60
- WVVI $4.79
- Resistance Level
- PULM $6.15
- WVVI $5.10
- Average True Range (ATR)
- PULM 0.28
- WVVI 0.21
- MACD
- PULM -0.05
- WVVI -0.02
- Stochastic Oscillator
- PULM 1.63
- WVVI 14.55
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.